Skip to content

Valesthesie

Active
Private limited companyfounded 20196 yrs activeVerdussenstraat 9, 2018 Antwerpen, BelgiumKBO/BCE: BE 0738.689.345
Summary

Valesthesie has been active since 2019 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €110,183 and a net result of €214,073. The figures fluctuate too strongly year-on-year for a reliable trend projection. Its solvency ranks better than 73% of 18230 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).

Risk analysisWatch ReportCompare
ValesthesieActiveChecked score 98/100
Risk analysis ReportCompare

Overview

What they do
Specialist medical practice
NACE 86220
1 site
How big
€132,336total assets 2025
Equity
€110,183
Profit
€214,073
Turnover not published (abridged schema)
Financially healthy?
98 Excellent Checked score 2025
Bankruptcy chance 12 m
0.1%
Who decides
Accounts 16 d early0 of 2 deeds read
Why 98- Limited track record+ Lower-failure-rate sector+ Annual accounts: healthy financial profile+ Growing equityLatest accounts filed on timeShow the evidence

Checked score

Score 2025
98 / 100
Excellent
Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability100=
Solvency100▲+62
Growth78▲+20
Track record100
Bankruptcy probability, 12 months
0.1% Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €10,000 at 30 days acceptable
Liquidity ample (current ratio 6.15 against 1.04 in 2024; short-term debt: 16.1% and cash: 40.8% of total assets), and 16.7% of the assets are financed with debt.
Credit check for your own amount and term

Show the recommended maximum : and see how the verdict changes with amount, term and advance.

Signals

Five signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Human health activities (NACE 86)
about 87% fewer bankruptcies
← fewer bankruptcies more bankruptcies →
raises risk · Limited track record
This company has not been active as long as an established one and statistically fails somewhat more often.
KBO · incorporation date
Age against the risk zone
highest failure risk from 2 to 8 years 6 years 0 10 y
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025
Solvency, return and age of the figures
Solvency
83.3%
Return on assets
161.8%
Age of the figures
9 mo
lowers risk · Growing equity
Reported equity is higher than in 2023 and did not fall compared with 2024. These amounts do not establish the cause of the change.
NBB · annual accounts 2025
Equity per financial year
202122232425
2020 to 2025 · latest year €110,183
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 15-07-2026, 16 days ahead of the deadline.
NBB · 6 filings
Deviation from the deadline
2025
16 d early
2024
28 d late
2023
28 d late
2022
31 d late
2021
3 d early
2020
4 d early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 6 accounts on average 11 days after the deadline; the sector median for financial year 2024 is 7 days before the deadline, and 36% of the sector filed late.

Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. Usually files around 28 August (4 of the last 5 filed years within 31 days of that day).
Companies Code · seven months
Position in the running window
02-10-2026 today31-12-2026 close31-07-2027 deadline
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage
  1. Annual accounts filedfiscal year 2025 · micro…
  2. Liquidity times 6current ratio 6.15
  3. Equity above €100,000Eq €110,183 ▲453%

Key points

  • Positive: Equity rose in 2025from €19,933 to €110,183 ▲ 453% View
  • Positive: Among the best 11% on net resultsector median €60,729 · 18,219 companies €214,073 View
  • Positive: 6 profitable years in a rowprofit 2025: €214,073 6 years View

By topic

Financials

Fiscal year
2025
Total assets
€132,336
Profit
€214,073
Solvency
83.3%
Total assets▼ 12.2%
Net result
20202025
Go to Financials

Timeline

Events
10
Since
2021
Next accounts
by 31-07-2027
  1. 15-07-2026Annual accounts filed
  2. 31-12-2025Liquidity times 6
  3. 31-12-2025Equity above €100,000
Go to Timeline

Company details

Sites
1
Legal form
Private limited company
Activity
Specialist medical practiceNACE 86220
Founded
03-12-2019
Year ends
31-12
Peppol
Reachable for e-invoices
Go to Company details

Go further with this company

How much credit can you give this customer, and on what term?Credit check What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check How does this company compare with its sector?Sector benchmark What changed in the latest annual accounts?What changed

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.

We would like to set cookies. That happens only with your consent. What we measure